企業プロフィール
Trevena 株価・ニュース・カタリスト
- ティッカー:
- TRVN
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.00 USD (0.00%)
終値
最終更新: 2026年8月17日
—
時価総額
株価変動の要因
Current closing-price context is not available for TRVN.
企業概要
事業概要
Trevena was a specialty neuroscience and pain company focused on opioid-sparing and CNS therapeutics. Its story centered on difficult pain and neurologic indications where commercial uptake depends on both clinical differentiation and regulatory execution.
所在地とセクター分類
Trevena was headquartered in the United States and listed on NASDAQ, placing it in the small-cap biopharmaceutical category. It sat in the high-risk neuroscience and pain niche rather than broad healthcare.
ビジネスモデルの特徴
The business model was driven by late-stage development, product commercialization attempts, and the ability to secure reimbursement and physician adoption. Investors watched clinical data, product launches, and the company's capital structure closely.
バイオ業界での位置付け
Trevena occupied a catalyst-sensitive small-cap CNS niche. It is best viewed as a legacy specialty-pharma story where execution risk and funding pressure were always central to the stock.
今後のカタリスト
- Trevena is now mostly a legacy / closeout story, so the catalysts are any remaining asset or strategic update rather than a fresh development milestone. The market no longer treats it as a live growth name.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。